ARCHIVES

FDA Committee Approves Two NDAs, Blocks One, Hears NCI Toxicology Plan

This article is from The Cancer Letter archive.

Vol. 05 No. 24 | June 15, 1979

Download PDF Visit The Full Archive

Related Articles

NCI Will Encourage More Activity In Environment Carcinogenesis

June 21, 1974

FDA Ponders Standards For “Retrospective Prospective” Studies

January 30, 2009

Funding Opportunities

March 7, 2003

Agency Expands Gleevec Label To Include Rare GIST Subset

February 24, 2012

Blood Vessel Growth Inhibitor May Be Tested Against KS

August 16, 1991

In Brief: David Johnson New ACCC President, William Dugan Named President Elect; Straus Resigns From NYMC

March 12, 1982